Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF

© 2023. The Author(s)..

Rapid, cost-effective, and sensitive diagnostic assays are essential for global tuberculosis (TB) control, especially in high TB burden, resource-limited settings. The current study was designed to evaluate diagnostic accuracy of Truenat MTB-Rif Dx (MolBio) in children less than 18 years of age, with symptoms suggestive of TB. Gastric aspirate, induced sputum, and broncho-alveolar lavage samples were subjected simultaneously to AFB-smear, GeneXpert MTB/RIF, liquid culture (MGIT-960) and Truenat MTB-Rif Dx. The index-test results were evaluated against microbiological reference standards (MRS). Truenat MTB-Rif Dx had a sensitivity of 57.1%, specificity of 92% against MRS. The sensitivity and specificity of the Truenat MTB-RIF Dx compared with liquid culture was 58.7% and 87.5% while GeneXpert MTB/RIF was 56% and 91.4%. The performance of both GeneXpert MTB/RIF and Truenat MTB-Rif Dx are comparable. Result of our study demonstrates that Truenat MTB-Rif can aid in early and efficient diagnosis of TB in children.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Scientific reports - 13(2023), 1 vom: 28. Apr., Seite 6976

Sprache:

Englisch

Beteiligte Personen:

Singh, Urvashi B [VerfasserIn]
Singh, Manjula [VerfasserIn]
Sharma, Sangeeta [VerfasserIn]
Mahajan, Neeraj [VerfasserIn]
Bala, Kiran [VerfasserIn]
Srivastav, Abhinav [VerfasserIn]
Singh, Kh Jitenkumar [VerfasserIn]
Rao, M V V [VerfasserIn]
Lodha, Rakesh [VerfasserIn]
Kabra, Sushil K [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 01.05.2023

Date Revised 10.05.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-023-32810-2

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM356207625